How to Evaluate AI Mental Health Tools: A Clinician's Framework

Why This Decision Feels Harder Than It Should

A few years ago, choosing practice software meant comparing two or three EHR platforms on price and calendar features. That comparison problem no longer exists. In its place is a sprawling, fast-moving category loosely labeled "AI mental health tools" that includes ambient note-takers, treatment-plan generators, client-facing chatbots, risk-detection add-ons, and outcome-tracking dashboards, all marketed with strikingly similar language about saving time and improving care.

The problem for clinicians and practice owners is that these tools are not interchangeable, even when their marketing pages read that way. A documentation assistant that drafts a SOAP note after a session carries a very different risk profile than a chatbot a client might use between sessions to process a panic attack. Treating them as the same category, and evaluating them with the same checklist, is how practices end up with compliance gaps, clinical documentation they can't fully stand behind, or tools that quietly reshape the therapeutic relationship without anyone deciding that should happen.

This guide is built for the clinician or practice owner who wants a structured way to evaluate what's actually in front of them, not a ranked list of products that will be outdated in a quarter.

Start by Mapping the Category, Not the Product

Before comparing features, sort any tool into one of two buckets: clinician-facing or client-facing. Clinician-facing tools sit on your side of the relationship. You review the output, you decide what goes in the chart, and the client's contact with the AI is indirect at most. Client-facing tools put the AI in direct contact with the person seeking support, sometimes with no clinician in the loop at all.

This distinction matters because the two categories were built, and are governed, very differently. General-purpose generative AI chatbots and wellness apps were not created to deliver mental health care, and the American Psychological Association has cautioned that engaging with these systems for mental health purposes can have unintended effects and even harm mental health ^[1]. A clinician evaluating a note-taking assistant is asking questions about accuracy and workflow fit. A clinician whose client mentions using a wellness chatbot between sessions is dealing with a completely different set of clinical and ethical considerations, including whether that use is undermining or supporting the treatment plan you've built together.

Once you know which bucket a tool falls into, the rest of the evaluation gets much more specific.

Where the Familiar Names Fit

A map is more useful than a ranking here, so this is the current landscape sorted into those two buckets. None of it is an endorsement or a review. Placement is the point, because the bucket a tool sits in determines which evaluation questions apply to it.

On the clinician-facing side, the most crowded shelf is documentation. Purpose-built therapy scribes like Mentalyc, Upheal, and Eleos Health record or summarize sessions and draft progress notes in SOAP, DAP, and similar formats for the clinician to review, and several extend into treatment-plan drafting. Frontera automates assessment reporting for autism care teams. The mainstream EHRs, including SimplePractice and TherapyNotes, now ship built-in AI note features of their own, which turns a standalone purchase decision into a comparison with what your existing platform may already include. Blueprint attaches AI-drafted notes to questionnaire-based outcome tracking built on measures like the PHQ-9 and GAD-7. A separate group, including Lyssn and Kintsugi, analyzes conversation or voice data to flag risk or measure treatment quality. That last group deserves its own consent conversation, because the analysis runs on the client's words and voice, not just on the clinician's paperwork.

On the client-facing side sit the chatbots and wellness companions. Wysa and Youper are structured, CBT-informed apps with published research behind them. Earkick focuses on in-the-moment support during spikes of anxiety or panic. Ash, built by Slingshot AI, is a chatbot designed specifically for open-ended emotional support conversations, and clare&me offers a similar companion by voice over an ordinary phone call. OpenSynaps AI pairs an AI chat companion with generated hypnosis, sophrology, and meditation sessions, and Headspace has folded an AI companion into what began as a meditation app, a reminder that this bucket stretches well past conversation into self-guided wellness content. The category sheds names as fast as it adds them: Woebot, for years the best-known name in the bucket, retired its consumer app in mid-2025 ^[5].

A third group sits deliberately between the buckets: platforms where the client uses an app between sessions but a licensed clinician assigns the work, sees the output, and stays accountable for the care. That middle ground is filling in fast. Jimini Health pairs its therapists with an AI assistant that stays involved between sessions, with every conversation visible to the care team. Sibly runs 24/7 text support where human coaches work alongside AI, mostly through employer programs. Limbic builds the intake and assessment chatbots that health systems use to screen and triage referrals under their own clinical governance. Evaluating tools in this group means borrowing questions from both lists, which is exactly why the sort has to come first.

Some of the best-funded names in the category are not tools a practice adopts at all. Spring Health sells mental health care through employers and health plans, and Legion Health runs a psychiatry service where AI handles scheduling, routine refills, and risk triage while clinicians keep every prescribing decision. If one of these crosses your desk, you are evaluating a referral destination or a benefits vendor, not software for your chart, and that is a different decision than anything on this checklist.

Evaluation Criterion One: Is the tool actually HIPAA compliant?

For any tool that touches protected health information, whether it's transcribing a session or drafting a progress note, HIPAA compliance is the first filter, and it is not satisfied by a vendor's homepage claim. Any AI tool that transcribes, stores, or processes session content on your behalf is legally a business associate under HIPAA, which means a signed Business Associate Agreement has to be in place before the tool ever touches real client information. Beyond the BAA itself, practices should be asking how long audio or transcripts are retained, whether that data is ever used to train the vendor's underlying models, and what encryption standards apply both in transit and at rest.

Only a qualified provider can diagnose mental health conditions, and that principle extends to how you frame any AI tool's role in your practice: even the best documentation assistant is not a substitute for your clinical judgment about what belongs in a client's record.

Evaluation Criterion Two: Does the tool save me time?

Documentation tools are usually sold on time saved, but the more useful question is time saved net of editing. A note generator that produces a fast first draft but consistently misses risk factors, omits relevant history, or flattens clinical nuance can cost more time in review than it saves in drafting, and it introduces a different kind of risk: a chart that looks complete but isn't. Before adopting any documentation tool at scale, run it against de-identified or fictional session scenarios that include the edge cases your practice actually sees, not just a straightforward intake.

This is also where the ethical dimension of evaluation matters most. A peer-reviewed framework synthesizing the ethics codes of the American Counseling Association, the American Psychological Association, the American Medical Association, and the National Association of Social Workers organizes AI evaluation around five pillars: autonomy and informed consent, beneficence and non-maleficence, confidentiality and transparency, justice and fairness, and professional accountability ^[2]. Running a candidate tool through those five questions, rather than just a features list, surfaces gaps that a vendor demo won't.

Evaluation Criterion Three: Is the tool legal where I practice?

What's permissible in one state may be restricted in another, and that gap is widening. Illinois has drawn one of the clearest legal lines to date: its Wellness and Oversight for Psychological Resources Act prohibits anyone from using AI to provide mental health and therapeutic decision-making, while explicitly allowing the use of AI for administrative and supplementary support services for licensed behavioral health professionals ^[3].

That same administrative-versus-clinical-decision-making distinction is showing up across other states, but the specifics, and the penalties for getting it wrong, differ. A practice owner operating across state lines, or serving clients who relocate, needs a habit of checking current law rather than assuming last year's compliance research still applies. Always consult a licensed mental health professional and, where regulatory questions arise, qualified legal counsel before making decisions about which AI tools your practice will adopt.

Building a Structured Pilot Instead of a Leap of Faith

The practices that adopt AI tools successfully tend to treat adoption as a pilot with defined checkpoints, not a single purchasing decision. That looks like testing a tool with fictional or de-identified scenarios first, updating informed consent language so clients know where AI is involved in their care even indirectly, calculating real monthly cost against your actual caseload rather than a marketing price point, and setting a 30 to 60 day review point where you ask whether the tool changed your documentation time, your clinical confidence in the output, and your compliance posture.

This structured approach matters more as adoption accelerates. Nearly one in three practitioners now use AI at least monthly in their practice, and more than half have used it to assist with their work at least once, according to APA's 2025 Practitioner Pulse Survey ^[4]. That pace of adoption means the tools available to your practice, and the guidance governing them, will likely look different again within a year. Building an internal evaluation habit now, rather than a one-time decision, is what keeps a practice from having to relearn this process every time the landscape shifts.

The Takeaway for Practice Owners

AI is not one decision for a practice to make; it's several smaller decisions bundled under one marketing term. Sorting tools by whether they face you or your client, verifying compliance infrastructure before a single session is recorded, and running new tools through an ethics-and-accuracy pilot before scaling them across a practice will build more confidence than any ranked buyer's guide. The regulatory and clinical ground here is still moving. A structured, repeatable way of asking the right questions is the only evaluation criterion that doesn't expire.